My group studies population genomics of (biological) aging, with a special focus on osteoarthritis and chronic pain. Focus is also on integrative genomics in population cohorts where multiple genomic levels are combined to understand and predict disease.
Results from these large-scale genomic studies are being pursued towards developments of (personalized) new treatments and prediction tools. Our work has resulted in a better understanding of genetics of osteoarthritis, chronic pain and (healthy) aging. Recent work has concentrated also on implementing genetic and genomic results in the clinic, starting with genetic profiles, which have a wide potential to improve healthcare.